Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Muneerah Aleissa, Pharm.D.

Concepts (57)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Muneerah Aleissa's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Muneerah Aleissa has written about over time.
Arthroplasty, Replacement, Hip, 1 publications between 2020 and 2020, average publication date June 2020. Cannabis, 1 publications between 2020 and 2020, average publication date June 2020. Adenosine Monophosphate, 1 publications between 2020 and 2020, average publication date December 2020. Alanine, 1 publications between 2020 and 2020, average publication date December 2020. Antiviral Agents, 1 publications between 2020 and 2020, average publication date December 2020. Aniline Compounds, 1 publications between 2021 and 2021, average publication date May 2021. Leukemia, Myeloid, Acute, 1 publications between 2021 and 2021, average publication date May 2021. Mycoses, 1 publications between 2021 and 2021, average publication date May 2021. Pyrazines, 1 publications between 2021 and 2021, average publication date May 2021. Triazoles, 1 publications between 2021 and 2021, average publication date May 2021. Antifungal Agents, 3 publications between 2021 and 2023, average publication date June 2022. Echinocandins, 1 publications between 2023 and 2023, average publication date April 2023. Opportunistic Infections, 1 publications between 2023 and 2023, average publication date November 2023.

To see the data from this visualization as text, click here.
Aleissa's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (57)
Explore
_
Co-Authors (27)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.